Group FH ORTHO announced the Launch of JARVIS the New Round Baseplate for Reverse Prosthesis in the USA!
January 20, 2025 09:18 ET
|
Group FH Ortho
Group FH ORTHO announced the Launch of JARVIS the New Round Baseplate for Reverse Prosthesis in the USA!
Heimsbrunn, France, January 20th, 2025
Enovis™ Announces Leadership Change to International Surgical Business
January 17, 2025 06:00 ET
|
Enovis Corporation
Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr....
Acuitive Technologies Receives FDA 510(k) Clearance for CITREPORE™, A New Synthetic Bioactive Bone Void Filler for Orthopedic Procedures
November 12, 2024 08:00 ET
|
Acuitive Technologies
Acuitive Technologies announced the FDA 510(k) clearance of CITREPORE™, a new synthetic bioactive bone void filler for orthopedic procedures.
Upswing Health Rounds Out Advisory Board to Drive AI-Powered Virtual Orthopedic Care
October 22, 2024 13:57 ET
|
Upswing Health
Upswing Health Rounds Out Advisory Board members with Brian Klepper, PhD and Doug Geinzer to Drive AI-Powered Virtual Orthopedic Care
Medical Products Market to hit USD 41.1 billion by 2032, says Global Market Insights Inc.
October 10, 2024 03:00 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Medical Products Market size was valued at USD 25.2 billion in 2023 and is projected to grow at a CAGR of 5.7% from 2024 to 2032, driven...
AOFAS Annual Meeting 2024 Highlights Orthopaedic Research and Innovation
September 24, 2024 14:00 ET
|
American Orthopaedic Foot & Ankle Society (AOFAS)
Rosemont, Ill., Sept. 24, 2024 (GLOBE NEWSWIRE) -- More than 900 foot and ankle orthopaedic surgeons, advanced health practitioners, orthopaedic residents, and medical students attended the American...
Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
September 09, 2024 15:50 ET
|
Enovis Corporation
WILMINGTON, DE, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical technology growth company, is pleased to announce the appointment of Tim Czartoski to the...
Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting
September 05, 2024 08:00 ET
|
Enovis Corporation
Wilmington, DE, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical technology company, announced today it will unveil its new Tarsoplasty Percutaneous Lapidus...
Autologous Cell Therapy Market Estimated to Grow USD 34.7 Billion by 2027, Rising at a 18.1% CAGR- Transparency Market Research, Inc.
August 21, 2024 11:09 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. , Aug. 21, 2024 (GLOBE NEWSWIRE) -- According to Transparency Market Research (TMR), the global autologous cell therapy market...
Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures
August 20, 2024 08:00 ET
|
Enovis Corporation
WILMINGTON, DE, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), an innovation-driven medical technology growth company, announced today the expansion of its EMPOWR Revision Knee™ system to...